Themis Medicare Limited (NSE:THEMISMED)
India · Delayed Price · Currency is INR 79.22
+5.04 (6.79%)
Apr 2, 2026, 3:29 PM IST
Themis Medicare Market Cap
Themis Medicare has a market cap or net worth of 7.28 billion as of April 2, 2026. Its market cap has decreased by -48.08% in one year.
Market Cap
7.28B
Enterprise Value
8.10B
Revenue
3.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
79.22
Market Cap Chart
Since July 26, 2001, Themis Medicare's market cap has increased from 94.35M to 7.28B, an increase of 7,611.45%. That is a compound annual growth rate of 19.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 7.28B | -21.51% |
| Dec 31, 2025 | 9.27B | -61.73% |
| Dec 31, 2024 | 24.22B | 23.62% |
| Dec 29, 2023 | 19.59B | 58.02% |
| Dec 30, 2022 | 12.40B | 42.22% |
| Dec 31, 2021 | 8.72B | 162.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 26.34B |
| Solara Active Pharma Sciences | 22.12B |
| Indoco Remedies | 17.29B |
| Windlas Biotech | 16.18B |
| Beta Drugs | 12.82B |
| Jagsonpal Pharmaceuticals | 12.43B |
| Ind-Swift Laboratories | 11.98B |
| Sakar Healthcare | 11.47B |